Bakdash G - Search Results

1

Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells.

Bakdash G, van Capel TM, Mason LM, Kapsenberg ML, de Jong EC. Bakdash G, et al. Vaccine. 2014 Oct 29;32(47):6294-302. doi: 10.1016/j.vaccine.2014.08.075. Epub 2014 Sep 16. Vaccine. 2014. PMID: 25236584

2

Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells.

van der Aar AM, Sibiryak DS, Bakdash G, van Capel TM, van der Kleij HP, Opstelten DJ, Teunissen MB, Kapsenberg ML, de Jong EC. van der Aar AM, et al. Among authors: bakdash g. J Allergy Clin Immunol. 2011 Jun;127(6):1532-40.e7. doi: 10.1016/j.jaci.2011.01.068. Epub 2011 Apr 17. J Allergy Clin Immunol. 2011. PMID: 21497886

3

Viral dsRNA-activated human dendritic cells produce IL-27, which selectively promotes cytotoxicity in naive CD8+ T cells.

de Groot R, van Beelen AJ, Bakdash G, Taanman-Kueter EW, de Jong EC, Kapsenberg ML. de Groot R, et al. Among authors: bakdash g. J Leukoc Biol. 2012 Sep;92(3):605-10. doi: 10.1189/jlb.0112045. Epub 2012 Jun 13. J Leukoc Biol. 2012. PMID: 22701040

4

Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells.

Bakdash G, Schneider LP, van Capel TM, Kapsenberg ML, Teunissen MB, de Jong EC. Bakdash G, et al. Hum Vaccin Immunother. 2013 Feb;9(2):250-8. doi: 10.4161/hv.22918. Epub 2013 Jan 4. Hum Vaccin Immunother. 2013. PMID: 23291929 Free PMC article.

5

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.

Bakdash G, Schreurs I, Schreibelt G, Tel J. Bakdash G, et al. Expert Rev Clin Immunol. 2014 Jul;10(7):915-26. doi: 10.1586/1744666X.2014.912561. Epub 2014 Apr 23. Expert Rev Clin Immunol. 2014. PMID: 24758519 Review.

6

Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells.

Bakdash G, Vogelpoel LT, van Capel TM, Kapsenberg ML, de Jong EC. Bakdash G, et al. Mucosal Immunol. 2015 Mar;8(2):265-78. doi: 10.1038/mi.2014.64. Epub 2014 Jul 16. Mucosal Immunol. 2015. PMID: 25027601

7

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Sköld AE, van Beek JJ, Sittig SP, Bakdash G, Tel J, Schreibelt G, de Vries IJ. Sköld AE, et al. Among authors: bakdash g. Cancer Immunol Immunother. 2015 Nov;64(11):1461-73. doi: 10.1007/s00262-015-1746-9. Epub 2015 Aug 15. Cancer Immunol Immunother. 2015. PMID: 26275446 Free PMC article.

8

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

Sittig SP, Bakdash G, Weiden J, Sköld AE, Tel J, Figdor CG, de Vries IJ, Schreibelt G. Sittig SP, et al. Among authors: bakdash g. Mediators Inflamm. 2016;2016:3605643. doi: 10.1155/2016/3605643. Epub 2016 Feb 7. Mediators Inflamm. 2016. PMID: 27057096 Free PMC article.

9

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Sköld AE, Mathan TSM, van Beek JJP, Flórez-Grau G, van den Beukel MD, Sittig SP, Wimmers F, Bakdash G, Schreibelt G, de Vries IJM. Sköld AE, et al. Among authors: bakdash g. Cancer Immunol Immunother. 2018 Sep;67(9):1425-1436. doi: 10.1007/s00262-018-2204-2. Epub 2018 Jul 13. Cancer Immunol Immunother. 2018. PMID: 30019146 Free PMC article.

10

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.

Kreutz M, Bakdash G, Dolen Y, Sköld AE, van Hout-Kuijer MA, de Vries IJ, Figdor CG. Kreutz M, et al. Among authors: bakdash g. Eur J Immunol. 2015 Oct;45(10):2798-809. doi: 10.1002/eji.201545583. Epub 2015 Sep 2. Eur J Immunol. 2015. PMID: 26255864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results